NO20024769L - Forbindelser og fremgangsmÕter for senking av kolesterolnivÕer uten Õ indusere hypertriglyceridemi - Google Patents

Forbindelser og fremgangsmÕter for senking av kolesterolnivÕer uten Õ indusere hypertriglyceridemi

Info

Publication number: NO20024769L
Authority: NO; Norway
Prior art keywords: methods; compounds; lowering cholesterol; cholesterol levels; inducing hypertriglyceridemia
Prior art date: 2000-04-06

Application number

NO20024769A

Other languages

English (en)

Norwegian (no)

Other versions

NO20024769D0 (no

Inventor

Vassilis I Zannis

Kyriakos E Kypreos

Original Assignee

Univ Boston

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-04-06

Filing date

2002-10-03

Publication date

2002-11-26

2001-04-05 Priority claimed from US09/827,854 external-priority patent/US20020123093A1/en

2002-10-03 Application filed by Univ Boston filed Critical Univ Boston

2002-10-03 Publication of NO20024769D0 publication Critical patent/NO20024769D0/no

2002-11-26 Publication of NO20024769L publication Critical patent/NO20024769L/no

Links

HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 title abstract 5
208000006575 hypertriglyceridemia Diseases 0.000 title abstract 3
230000001939 inductive effect Effects 0.000 title abstract 3
150000001875 compounds Chemical class 0.000 title 1
241000124008 Mammalia Species 0.000 abstract 3
201000001320 Atherosclerosis Diseases 0.000 abstract 2
101150037123 APOE gene Proteins 0.000 abstract 1
101100216294 Danio rerio apoeb gene Proteins 0.000 abstract 1
235000012000 cholesterol Nutrition 0.000 abstract 1
102000039446 nucleic acids Human genes 0.000 abstract 1
108020004707 nucleic acids Proteins 0.000 abstract 1
150000007523 nucleic acids Chemical class 0.000 abstract 1
229920001184 polypeptide Polymers 0.000 abstract 1
102000004196 processed proteins & peptides Human genes 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Molecular Biology (AREA)
Pharmacology & Pharmacy (AREA)
Genetics & Genomics (AREA)
Animal Behavior & Ethology (AREA)
Biophysics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Toxicology (AREA)
Zoology (AREA)
General Chemical & Material Sciences (AREA)
Biochemistry (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

NO20024769A 2000-04-06 2002-10-03 Forbindelser og fremgangsmÕter for senking av kolesterolnivÕer uten Õ indusere hypertriglyceridemi NO20024769L (no)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US54438600A	2000-04-06	2000-04-06
US67908800A	2000-10-04	2000-10-04
US09/827,854 US20020123093A1 (en)	2000-04-06	2001-04-05	Compounds and methods for lowering cholesterol levels without inducing hypertrigylceridemia
PCT/US2001/011358 WO2001077136A1 (en)	2000-04-06	2001-04-06	Compounds and methods for lowering cholesterol levels without inducing hypertriglyceridemia

Publications (2)

Publication Number	Publication Date
NO20024769D0 NO20024769D0 (no)	2002-10-03
NO20024769L true NO20024769L (no)	2002-11-26

Family

ID=27415432

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20024769A NO20024769L (no)	2000-04-06	2002-10-03	Forbindelser og fremgangsmÕter for senking av kolesterolnivÕer uten Õ indusere hypertriglyceridemi

Country Status (9)

Country	Link
US (1)	US20060142200A1 (de)
EP (1)	EP1274717B1 (de)
JP (1)	JP2003530835A (de)
AT (1)	ATE387459T1 (de)
AU (2)	AU2001253233B2 (de)
CA (1)	CA2405870A1 (de)
MX (1)	MXPA02009804A (de)
NO (1)	NO20024769L (de)
WO (1)	WO2001077136A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE533783T1 (de) *	2006-12-13	2011-12-15	Univ California	Potente und selektive mittlersubstanzen von cholesterolefflux
EP3191578B1 (de) *	2014-09-12	2020-11-04	Whitehead Institute for Biomedical Research	Zellen zur expression von apolipoprotein e und verwendungen davon
EP3692158A4 (de)	2017-10-03	2021-08-04	Prevail Therapeutics, Inc.	Gentherapien für lysosomale erkrankungen
MX2020004005A (es)	2017-10-03	2020-10-05	Prevail Therapeutics Inc	Terapias genicas para los trastornos lisosomales.
CA3121211A1 (en) *	2018-11-28	2020-06-04	Prevail Therapeutics, Inc.	Gene therapies for neurodegenerative disease
KR20230112672A (ko) *	2020-11-25	2023-07-27	프리베일 테라퓨틱스, 인크.	신경변성 질환을 위한 유전자 요법
WO2025144884A1 (en) *	2023-12-26	2025-07-03	Kisbee Therapeutics, Inc.	Apoe lipoprotein mimetics and methods of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69334238D1 (de) *	1992-09-25	2008-09-25	Aventis Pharma Sa	Adenovirus vektoren für die übertragung fremder gene in zellen des zentralen nervensystems, insbesondere im gehirn
WO1994027612A1 (en) *	1993-05-20	1994-12-08	Baylor College Of Medicine	Genetic therapy for cardiovascular disease
US5811243A (en) *	1993-08-31	1998-09-22	Duke University	Methods and compositions for binding tau and MAP2c proteins
AU7142796A (en) *	1995-10-02	1997-04-28	Erasmus University Rotterdam	Diagnosis method and reagents

2001
- 2001-04-06 AT AT01926716T patent/ATE387459T1/de not_active IP Right Cessation
- 2001-04-06 JP JP2001575606A patent/JP2003530835A/ja not_active Withdrawn
- 2001-04-06 EP EP01926716A patent/EP1274717B1/de not_active Expired - Lifetime
- 2001-04-06 WO PCT/US2001/011358 patent/WO2001077136A1/en not_active Ceased
- 2001-04-06 MX MXPA02009804A patent/MXPA02009804A/es active IP Right Grant
- 2001-04-06 AU AU2001253233A patent/AU2001253233B2/en not_active Ceased
- 2001-04-06 CA CA002405870A patent/CA2405870A1/en not_active Abandoned
- 2001-04-06 AU AU5323301A patent/AU5323301A/xx active Pending
2002
- 2002-10-03 NO NO20024769A patent/NO20024769L/no not_active Application Discontinuation
2006
- 2006-02-24 US US11/361,788 patent/US20060142200A1/en not_active Abandoned

Also Published As

Publication number	Publication date
ATE387459T1 (de)	2008-03-15
AU5323301A (en)	2001-10-23
US20060142200A1 (en)	2006-06-29
EP1274717A4 (de)	2004-07-14
MXPA02009804A (es)	2003-07-14
JP2003530835A (ja)	2003-10-21
NO20024769D0 (no)	2002-10-03
CA2405870A1 (en)	2001-10-18
AU2001253233B2 (en)	2006-12-07
WO2001077136A1 (en)	2001-10-18
EP1274717A1 (de)	2003-01-15
EP1274717B1 (de)	2008-02-27

Similar Documents

Publication	Publication Date	Title
EA200501772A1 (ru)	2006-10-27	Способы измерения экспрессии генов из фиксированного и залитого в парафин образца ткани
WO2001042504A3 (en)	2002-08-29	Detection of extracellular tumor-associated nucleic acid in blood plasma or serum
EP1750771A4 (de)	2007-11-07	Pankreasinsel-mikro-rna und verfahren zu ihrer unterdrückung
EP1687283A4 (de)	2008-09-24	Für die bestimmung von fk506 geeignetes verfahren und zusammensetzung
DE60035232D1 (de)	2007-07-26	(S,S)-Reboxetine zur Behandlung von chronischen Erschöpfungssyndrom
DK1615952T3 (da)	2012-02-13	Fremgangsmåder til behandling af betændelsestilstande med specifikke, til humant angiopoietin-2-bindende midler
SG155054A1 (en)	2009-09-30	Human anti- neutralizing antibodies as selective pathway inhibitors
ATE413386T1 (de)	2008-11-15	Ppar-gamma modulatoren
EP1509237A4 (de)	2006-07-12	Verfahren zur behandlung von angiogenese, tumorwachstum und metastasen
DE10082139T1 (de)	2001-10-04	Zusammensetzung zur Behandlung von Reibungspaaren
MXPA03001930A (es)	2003-06-19	Moleculas pseudorreceptoras de factor de necrosis tumoral y uso de las mismas.
ATE275411T1 (de)	2004-09-15	Verwendung von phyllanthus zur behandlung von chronisch entzündlichen und fibrotischen prozessen
WO2002066981A3 (en)	2003-04-24	Monitoring soluble endothelial protein c receptor levels in anticoagulant therapy
DK1537140T3 (da)	2013-04-15	Nukleinsyre og tilsvarende protein betegnet 161P2F10B, der er anvendelige i behandling og detektering af cancer
WO2006060680A3 (en)	2007-01-25	Mda-7 protein variants having antiproliferative activity
NO20024769D0 (no)	2002-10-03	Forbindelser og fremgangsmåter for senking av kolesterolnivåer uten å indusere hypertriglyceridemi
WO2004071430A3 (en)	2006-02-16	RNAi TARGETING OF VIRUSES
EP1594480A4 (de)	2007-08-29	Verfahren zur behandlung von chronischer herzinsuffizienz und/oder erhöhtem cholesterinspiegel
DK1372719T3 (da)	2013-01-21	Nukleinsyre og tilsvarende protein betegnet 125P5C8, der er anvendelig i behandling og påvisning af cancer
WO2002010388A3 (en)	2002-08-29	C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF
DK1196442T3 (da)	2006-05-08	VGF-polypeptider og fremgangsmåder til behandling af VGF-relaterede lidelser
WO2001044280A3 (en)	2001-11-29	Methods and compositions for the manufacture of replication incompetent adenovirus
NO20023737D0 (no)	2002-08-07	Fremgangsmåte og preparater for behandling av en inflammatorisk lidelse
ATE479705T1 (de)	2010-09-15	Reduzierter slam abhängiger zell eintritt
EP1715896A4 (de)	2009-01-07	Antisense-oligonucleotide gegen ribonucleotid-reductase r2 und ihre verwendungen in kombinationstherapien zur behandlung von krebs

Legal Events

Date	Code	Title	Description
2010-08-23	FC2A	Withdrawal, rejection or dismissal of laid open patent application